![](/img/cover-not-exists.png)
Baseline neutrophil-to-lymphocyte ratio and PD-L1 expression level or LDH value may predict outcome of patients with high PD-L1 advanced non-small cell lung cancer treated with first-line pembrolizumab
Banna, G., Signorelli, D., Metro, G., Galetta, D., De Toma, A., Cantale, O., Banini, M., Friedlaender, A., Pizzutillo, P., Garassino, M., Addeo, A.Volume:
139
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(20)30162-8
Date:
January, 2020
File:
PDF, 134 KB
2020